These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Exact name of Registrant as specified in its charter)
|
||
|
Maryland
|
38-3041398
|
|
|
(State of incorporation)
|
(IRS Employer
Identification No.)
|
|
|
200 International Circle, Suite 3500, Hunt Valley, MD 21030
|
||
|
(Address of principal executive offices)
|
||
|
(410) 427-1700
|
||
|
(Telephone number, including area code)
|
||
|
Page
No.
|
||
|
PART I
|
Financial Information
|
|
|
Item 1.
|
Financial Statements:
|
|
|
March 31, 2011 (unaudited) and December 31, 2010
|
2
|
|
|
Three months ended March 31, 2011 and 2010
|
3
|
|
|
Three months ended March 31, 2011 (unaudited)
|
4
|
|
|
Three months ended March 31, 2011 and 2010
|
5
|
|
|
March 31, 2011 (unaudited)
|
6
|
|
|
Item 2.
|
20 | |
|
Item 3.
|
32
|
|
|
Item 4.
|
32
|
|
|
PART II
|
Other Information
|
|
|
Item 1.
|
33
|
|
|
Item 1A.
|
33
|
|
|
Item 6.
|
35
|
|
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Real estate properties
|
||||||||
|
Land and buildings
|
$ | 2,335,799 | $ | 2,366,856 | ||||
|
Less accumulated depreciation
|
(395,918 | ) | (380,995 | ) | ||||
|
Real estate properties – net
|
1,939,881 | 1,985,861 | ||||||
|
Mortgage notes receivable – net
|
110,323 | 108,557 | ||||||
| 2,050,204 | 2,094,418 | |||||||
|
Other investments – net
|
28,348 | 28,735 | ||||||
| 2,078,552 | 2,123,153 | |||||||
|
Assets held for sale – net
|
811 | 670 | ||||||
|
Total investments
|
2,079,363 | 2,123,823 | ||||||
|
Cash and cash equivalents
|
3,381 | 6,921 | ||||||
|
Restricted cash
|
20,180 | 22,399 | ||||||
|
Accounts receivable – net
|
95,981 | 92,819 | ||||||
|
Other assets
|
58,698 | 57,172 | ||||||
|
Operating assets for owned and operated properties
|
324 | 873 | ||||||
|
Total assets
|
$ | 2,257,927 | $ | 2,304,007 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Revolving line of credit
|
$ | 69,000 | $ | — | ||||
|
Secured borrowings
|
200,378 | 201,296 | ||||||
|
Unsecured borrowings – net
|
975,573 | 975,669 | ||||||
|
Accrued expenses and other liabilities
|
117,317 | 121,859 | ||||||
|
Operating liabilities for owned and operated properties
|
470 | 1,117 | ||||||
|
Total liabilities
|
1,362,738 | 1,299,941 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock issued and outstanding – 4,340 shares Series D with an aggregate liquidation preference of $108,488 as of December 31, 2010
|
$ | — | $ | 108,488 | ||||
|
Common stock $.10 par value authorized – 200,000 shares issued and outstanding – 101,371 shares as of March 31, 2011 and 99,233 as of December 31, 2010
|
10,137 | 9,923 | ||||||
|
Common stock – additional paid-in-capital
|
1,425,186 | 1,376,131 | ||||||
|
Cumulative net earnings
|
574,911 | 580,824 | ||||||
|
Cumulative dividends paid
|
(1,115,045 | ) | (1,071,300 | ) | ||||
|
Total stockholders’ equity
|
895,189 | 1,004,066 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 2,257,927 | $ | 2,304,007 | ||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Revenue
|
||||||||
|
Rental income
|
$ | 66,337 | $ | 47,209 | ||||
|
Mortgage interest income
|
3,498 | 2,614 | ||||||
|
Other investment income – net
|
641 | 746 | ||||||
|
Miscellaneous
|
- | 3,729 | ||||||
|
Nursing home revenues of owned and operated assets
|
- | 4,380 | ||||||
|
Total operating revenues
|
70,476 | 58,678 | ||||||
|
Expenses
|
||||||||
|
Depreciation and amortization
|
25,218 | 14,687 | ||||||
|
General and administrative
|
5,226 | 3,710 | ||||||
|
Acquisition costs
|
45 | 220 | ||||||
|
Impairment loss on real estate properties
|
24,971 | - | ||||||
|
Nursing home expenses of owned and operated assets
|
230 | 4,572 | ||||||
|
Total operating expenses
|
55,690 | 23,189 | ||||||
|
Income before other income and expense
|
14,786 | 35,489 | ||||||
|
Other income (expense)
|
||||||||
|
Interest income
|
11 | 15 | ||||||
|
Interest expense
|
(20,000 | ) | (13,575 | ) | ||||
|
Interest – amortization of deferred financing costs
|
(694 | ) | (978 | ) | ||||
|
Interest – refinancing costs
|
(16 | ) | - | |||||
|
Total other expense
|
(20,699 | ) | (14,538 | ) | ||||
|
Net (loss) income
|
(5,913 | ) | 20,951 | |||||
|
Preferred stock dividends
|
(1,691 | ) | (2,271 | ) | ||||
|
Preferred stock redemption
|
(3,472 | ) | - | |||||
|
Net (loss) income available to common stockholders
|
$ | (11,076 | ) | $ | 18,680 | |||
|
(Loss) income per common share available to common shareholders:
|
||||||||
|
Basic:
|
||||||||
|
Net (loss) income
|
$ | (0.11 | ) | $ | 0.21 | |||
|
Diluted:
|
||||||||
|
Net (loss) income
|
$ | (0.11 | ) | $ | 0.21 | |||
|
Dividends declared and paid per common share
|
$ | 0.37 | $ | 0.32 | ||||
|
Weighted-average shares outstanding, basic
|
100,074 | 88,840 | ||||||
|
Weighted-average shares outstanding, diluted
|
100,086 | 88,961 | ||||||
|
Components of other comprehensive income:
|
||||||||
|
Net (loss) income
|
$ | (5,913 | ) | $ | 20,951 | |||
|
Unrealized gain on other investments
|
- | 38 | ||||||
|
Total comprehensive (loss) income
|
$ | (5,913 | ) | $ | 20,989 | |||
|
Preferred
Stock
|
Common Stock Par Value
|
Additional
Paid-in Capital
|
Cumulative
Net Earnings
|
Cumulative
Dividends
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2010 (99,233 common shares)
|
$ | 108,488 | $ | 9,923 | $ | 1,376,131 | $ | 580,824 | $ | (1,071,300 | ) | $ | 1,004,066 | |||||||||||
|
Issuance of common stock:
|
||||||||||||||||||||||||
|
Grant of restricted stock (13 shares at $22.00 per share)
|
— | 1 | (1 | ) | — | — | — | |||||||||||||||||
|
Amortization of restricted stock
|
— | — | 1,465 | — | — | 1,465 | ||||||||||||||||||
|
Vesting of restricted stock (grants 68 shares)
|
— | 7 | (1,261 | ) | — | — | (1,254 | ) | ||||||||||||||||
|
Dividend reinvestment plan (795 shares at $22.08 per share)
|
— | 80 | 17,445 | — | — | 17,525 | ||||||||||||||||||
|
Grant of stock as payment of directors fees (2 shares at an average of $22.35 per share)
|
— | — | 37 | — | — | 37 | ||||||||||||||||||
|
Equity Shelf Program (1,261 shares at $22.78 per share, net of issuance costs)
|
— | 126 | 27,982 | — | — | 28,108 | ||||||||||||||||||
|
Preferred stock redemption
|
(108,488 | ) | — | 3,388 | — | (3,472 | ) | (108,572 | ) | |||||||||||||||
|
Net loss
|
— | — | — | (5,913 | ) | — | (5,913 | ) | ||||||||||||||||
|
Common dividends ($0.37 per share).
|
— | — | — | — | (37,068 | ) | (37,068 | ) | ||||||||||||||||
|
Preferred dividends (Series D of $0.74 per share)
|
— | — | — | — | (3,205 | ) | (3,205 | ) | ||||||||||||||||
|
Balance at March 31, 2011 (101,371 common shares)
|
$ | — | $ | 10,137 | $ | 1,425,186 | $ | 574,911 | $ | (1,115,045 | ) | $ | 895,189 | |||||||||||
|
Three Months Ended
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cash flows from operating activities
|
||||||||
|
Net (loss) income
|
$ | (5,913 | ) | $ | 20,951 | |||
|
Adjustment to reconcile net income to cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
25,218 | 14,687 | ||||||
|
Impairment loss on real estate properties
|
24,971 | — | ||||||
|
Amortization of deferred financing costs
|
694 | 978 | ||||||
|
Restricted stock amortization expense
|
1,479 | 839 | ||||||
|
Amortization of in-place leases
|
(1,616 | ) | — | |||||
|
Amortization of straightline mortgage interest income
|
(421 | ) | — | |||||
|
Other
|
(38 | ) | (98 | ) | ||||
|
Change in operating assets and liabilities – net of amounts assumed/acquired:
|
||||||||
|
Accounts receivable, net
|
(93 | ) | 90 | |||||
|
Straight-line rent
|
(3,403 | ) | (1,946 | ) | ||||
|
Lease inducement
|
755 | (276 | ) | |||||
|
Other operating assets and liabilities
|
(2,829 | ) | 3,491 | |||||
|
Operating assets and liabilities for owned and operated properties
|
(98 | ) | 81 | |||||
|
Net cash provided by operating activities
|
38,706 | 38,797 | ||||||
|
Cash flows from investing activities
|
||||||||
|
Placement of mortgage loans
|
(1,749 | ) | — | |||||
|
Proceeds from sale of real estate investments
|
— | 28 | ||||||
|
Capital improvements and funding of other investments
|
(4,325 | ) | (9,139 | ) | ||||
|
Proceeds from other investments
|
980 | 461 | ||||||
|
Investments in other investments
|
(593 | ) | (14,322 | ) | ||||
|
Collection of mortgage principal – net
|
20 | 30 | ||||||
|
Net cash used in investing activities
|
(5,667 | ) | (22,942 | ) | ||||
|
Cash flows from financing activities
|
||||||||
|
Proceeds from credit facility borrowings
|
117,000 | 6,000 | ||||||
|
Payments on credit facility borrowings
|
(48,000 | ) | (100,100 | ) | ||||
|
Receipts of other long-term borrowings
|
— | 196,556 | ||||||
|
Payments of other long-term borrowings
|
(604 | ) | (59,354 | ) | ||||
|
Payment of financing related costs
|
(534 | ) | (4,291 | ) | ||||
|
Receipts from dividend reinvestment plan
|
17,525 | 12,214 | ||||||
|
Net proceeds from issuance of common stock
|
28,108 | 36,739 | ||||||
|
Payments from exercised options and restricted stock – net
|
(1,254 | ) | 4 | |||||
|
Dividends paid
|
(40,268 | ) | (30,599 | ) | ||||
|
Redemption of preferred stock
|
(108,552 | ) | — | |||||
|
Net cash (used in) provided by financing activities
|
(36,579 | ) | 57,169 | |||||
|
(Decrease) increase in cash and cash equivalents
|
(3,540 | ) | 73,024 | |||||
|
Cash and cash equivalents at beginning of period
|
6,921 | 2,170 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 3,381 | $ | 75,194 | ||||
|
Interest paid during the period, net of amounts capitalized
|
$ | 16,896 | $ | 7,814 | ||||
|
Non-cash investing activities
|
||||||||
|
Non-cash settlement of mortgage obligations
|
$ | — | $ | (12,395 | ) | |||
|
Non-cash acquisition of real estate properties
|
— | 12,395 | ||||||
|
Net non-cash investing activities
|
$ | — | $ | — | ||||
| March 31, | December 31, | ||||||||
|
2011
|
2010
|
||||||||
|
(in thousands)
|
|||||||||
|
Contractual receivables
|
$ | 7,870 | $ | 5,354 | |||||
|
Straight-line receivables
|
66,201 | 62,423 | |||||||
|
Lease inducements
|
28,271 | 29,026 | |||||||
|
Allowance
|
(6,361 | ) | (3,984 | ) | |||||
|
Accounts receivable – net
|
$ | 95,981 | $ | 92,819 | |||||
|
Pro Forma
|
||||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands, except per share amount, unaudited)
|
||||||||
|
Revenues
|
$ | 70,476 | $ | 75,640 | ||||
|
Net (loss) income available to common stockholders
|
(11,076 | ) | 22,473 | |||||
|
Earnings per share – diluted:
|
||||||||
|
Net (loss) income available to common stockholders – as reported
|
$ | (0.11 | ) | $ | 0.21 | |||
|
Net (loss) income available to common stockholders – pro forma
|
(0.11 | ) | 0.25 | |||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands)
|
||||||||
|
Nursing home revenues
|
$ | — | $ | 4,380 | ||||
|
Nursing home expenses
|
230 | 4,572 | ||||||
|
Loss from nursing home operations
|
$ | (230 | ) | $ | (192 | ) | ||
|
Three Months Ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands)
|
||||||||
|
Stock-based compensation expense
|
$ | 1,479 | $ | 839 | ||||
|
Shares/ Units
|
Grant Date Average Fair Value Per Unit/ Share
|
Total Compensation Cost
(in millions)
|
Weighted Average Period of Expense Recognition (in months)
|
Unrecognized Compensation Cost
(in millions)
|
||||||||||||||||
|
Restricted stock
|
428,503 | $ | 22.44 | $ | 9.6 | 36 | $ | 8.8 | ||||||||||||
|
2011 Annual PRSUs
|
124,244 | $ | 11.04 | 1.4 | 12 | 1.0 | ||||||||||||||
|
Multi-year TSR PRSUs
|
279,550 | $ | 11.06 | 3.1 | 48 | 2.9 | ||||||||||||||
|
Multi-year relative TSR PRSUs
|
93,183 | $ | 12.26 | 1.1 | 48 | 1.1 | ||||||||||||||
|
Total
|
925,480 | $ | 16.45 | $ | 15.2 | $ | 13.8 | |||||||||||||
|
Current
|
March 31
|
December 31,
|
||||||||||||||
|
Maturity
|
Rate
|
2011
|
2010
|
|||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Secured borrowings:
|
||||||||||||||||
|
Revolving lines of credit
|
2014
|
4.34% | $ | 69,000 | $ | — | ||||||||||
|
HUD Berkadia mortgages
(1)
|
2036 - 2040 | 6.61% | 65,731 | 66,128 | ||||||||||||
|
HUD Capital Funding mortgages
|
2040 - 2045 | 4.85% | 134,647 | 135,168 | ||||||||||||
|
Total secured borrowings
|
200,378 | 201,296 | ||||||||||||||
|
Unsecured borrowings:
|
||||||||||||||||
|
2016 Notes
|
2016 | 7.0% | $ | 175,000 | $ | 175,000 | ||||||||||
|
2020 Notes
|
2020 | 7.5% | 200,000 | 200,000 | ||||||||||||
|
2022 Notes
|
2022 | 6.75% | 575,000 | 575,000 | ||||||||||||
|
Subordinated debt
|
2021 | 9.0% | 21,356 | 21,403 | ||||||||||||
| 971,356 | 971,403 | |||||||||||||||
|
Premium
|
4,217 | 4,266 | ||||||||||||||
|
Total unsecured borrowings
|
975,573 | 975,669 | ||||||||||||||
|
Totals
–
net
|
$ | 1,244,951 | $ | 1,176,965 | ||||||||||||
|
(1)
|
Reflects the weighted average interest rate on the mortgages.
|
|
2011
|
2010
|
|||||||||||||||
|
Carrying
Amount
|
Fair
Value
|
Carrying
Amount
|
Fair
Value
|
|||||||||||||
|
Assets:
|
(in thousands)
|
|||||||||||||||
|
Cash and cash equivalents
|
$ | 3,381 | $ | 3,381 | $ | 6,921 | $ | 6,921 | ||||||||
|
Restricted cash
|
20,180 | 20,180 | 22,399 | 22,399 | ||||||||||||
|
Mortgage notes receivable – net
|
110,323 | 111,568 | 108,557 | 109,610 | ||||||||||||
|
Other investments – net
|
28,348 | 26,525 | 28,735 | 25,317 | ||||||||||||
|
Totals
|
$ | 162,232 | $ | 161,654 | $ | 166,612 | $ | 164,247 | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Revolving lines of credit
|
$ | 69,000 | $ | 69,000 | $ | — | $ | — | ||||||||
|
7.00% Notes due 2016 – net
|
174,259 | 186,985 | 174,221 | 187,079 | ||||||||||||
|
7.50% Notes due 2020 – net
|
196,944 | 218,027 | 196,857 | 212,837 | ||||||||||||
|
6.75% Notes due 2022 – net
|
583,014 | 610,573 | 583,188 | 576,019 | ||||||||||||
|
HUD debt
(1)
|
200,378 | 213,692 | 201,296 | 214,643 | ||||||||||||
|
Subordinated debt
(1)
|
21,356 | 24,090 | 21,403 | 23,248 | ||||||||||||
|
Totals
|
$ | 1,244,951 | $ | 1,322,367 | $ | 1,176,965 | $ | 1,213,826 | ||||||||
|
(1)
|
The carrying value of debt includes a fair value adjustment to reflect value of the debt assumed as part of the June 29, 2010 acquisition of the HUD portfolio.
|
|
·
|
Cash and cash equivalents and restricted cash: The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days).
|
|
·
|
Mortgage notes receivable: The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings.
|
|
·
|
Other investments: Other investments are primarily comprised of: (i) notes receivable and (ii) an investment in redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings. The fair value of the investment in the unconsolidated business is estimated using quoted market value and considers the terms of the underlying arrangement.
|
|
·
|
Revolving lines of credit: The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates.
|
|
·
|
Senior notes and other long-term borrowings: The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party.
|
|
Three Months Ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands, except per share amounts)
|
||||||||
|
Numerator:
|
||||||||
|
Net (loss) income
|
$ | (5,913 | ) | $ | 20,951 | |||
|
Preferred stock dividends
|
(1,691 | ) | (2,271 | ) | ||||
|
Preferred stock redemption
|
(3,472 | ) | — | |||||
|
Numerator for net income available to common per share - basic and diluted
|
$ | (11,076 | ) | $ | 18,680 | |||
|
Denominator:
|
||||||||
|
Denominator for basic earnings per share
|
100,074 | 88,840 | ||||||
|
Effect of dilutive securities:
|
||||||||
|
Restricted stock
|
— | 109 | ||||||
|
Stock option incremental shares
|
— | 10 | ||||||
|
Deferred stock
|
12 | 2 | ||||||
|
Denominator for diluted earnings per share
|
100,086 | 88,961 | ||||||
|
Earnings per share – basic:
|
||||||||
|
Net (loss) income – basic
|
$ | (0.11 | ) | $ | 0.21 | |||
|
Earnings per share – diluted:
|
||||||||
|
Net (loss) income – diluted
|
$ | (0.11 | ) | $ | 0.21 | |||
|
March 31, 2011
|
||||||||||||||||
|
Issuer & Subsidiary Guarantors
|
Non – Guarantor Subsidiaries
|
Elimination Company
|
Consolidated
|
|||||||||||||
|
Land and buildings
|
$ | 2,022,453 | $ | 313,346 | $ | — | $ | 2,335,799 | ||||||||
|
Less accumulated depreciation
|
(384,164 | ) | (11,754 | ) | — | (395,918 | ) | |||||||||
|
Real estate properties – net
|
1,638,289 | 301,592 | — | 1,939,881 | ||||||||||||
|
Mortgage notes receivable – net
|
110,323 | — | — | 110,323 | ||||||||||||
| 1,748,612 | 301,592 | — | 2,050,204 | |||||||||||||
|
Other investments – net
|
28,348 | — | — | 28,348 | ||||||||||||
| 1,776,960 | 301,592 | — | 2,078,552 | |||||||||||||
|
Assets held for sale – net
|
811 | — | — | 811 | ||||||||||||
|
Total investments
|
1,777,771 | 301,592 | — | 2,079,363 | ||||||||||||
|
Cash and cash equivalents
|
3,381 | — | — | 3,381 | ||||||||||||
|
Restricted cash
|
7,691 | 12,489 | — | 20,180 | ||||||||||||
|
Accounts receivable – net
|
94,266 | 1,715 | — | 95,981 | ||||||||||||
|
Investment in affiliates
|
79,337 | — | (79,337 | ) | — | |||||||||||
|
Other assets
|
37,411 | 21,287 | — | 58,698 | ||||||||||||
|
Operating assets for owned and operated properties
|
324 | — | — | 324 | ||||||||||||
|
Total assets
|
$ | 2,000,181 | $ | 337,083 | (79,337 | ) | $ | 2,257,927 | ||||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||||||||||
|
Revolving line of credit
|
$ | 69,000 | $ | — | $ | — | $ | 69,000 | ||||||||
|
Secured borrowings
|
— | 200,378 | — | 200,378 | ||||||||||||
|
Unsecured borrowings – net
|
954,217 | 21,356 | — | 975,573 | ||||||||||||
|
Accrued expenses and other liabilities
|
81,305 | 36,012 | — | 117,317 | ||||||||||||
|
Intercompany payable
|
— | 74,868 | (74,868 | ) | — | |||||||||||
|
Operating liabilities for owned and operated properties
|
470 | — | — | 470 | ||||||||||||
|
Total liabilities
|
1,104,992 | 332,614 | (74,868 | ) | 1,362,738 | |||||||||||
|
Stockholders’ equity:
|
||||||||||||||||
|
Common stock $.10 par value authorized – 200,000 shares issued and outstanding – 101,371 shares as of March 31, 2011 and 99,233 as of December 31, 2010
|
10,137 | — | — | 10,137 | ||||||||||||
|
Common stock – additional paid-in-capital
|
1,425,186 | — | — | 1,425,186 | ||||||||||||
|
Cumulative net earnings
|
574,911 | 4,469 | (4,469 | ) | 574,911 | |||||||||||
|
Cumulative dividends paid
|
(1,115,045 | ) | — | — | (1,115,045 | ) | ||||||||||
|
Total stockholders’ equity
|
895,189 | 4,469 | (4,469 | ) | 895,189 | |||||||||||
|
Total liabilities and stockholders’ equity
|
$ | 2,000,181 | $ | 337,083 | $ | (79,337 | ) | $ | 2,257,927 | |||||||
|
Three Months Ended March 31, 2011
|
||||||||||||||||
|
Issuer & Subsidiary Guarantors
|
Non – Guarantor Subsidiaries
|
Elimination
|
Consolidated
|
|||||||||||||
|
Revenue
|
||||||||||||||||
|
Rental income
|
$ | 57,843 | $ | 8,494 | $ | - | $ | 66,337 | ||||||||
|
Mortgage interest income
|
3,498 | - | - | 3,498 | ||||||||||||
|
Other investment income – net
|
641 | - | - | 641 | ||||||||||||
|
Nursing home revenues of owned and operated assets
|
- | - | - | - | ||||||||||||
|
Total operating revenues
|
61,982 | 8,494 | - | 70,476 | ||||||||||||
|
Expenses
|
||||||||||||||||
|
Depreciation and amortization
|
21,533 | 3,685 | - | 25,218 | ||||||||||||
|
General and administrative
|
5,143 | 83 | - | 5,226 | ||||||||||||
|
Acquisition costs
|
45 | - | - | 45 | ||||||||||||
|
Impairment loss on real estate properties
|
24,971 | - | - | 24,971 | ||||||||||||
|
Nursing home expenses of owned and operated assets
|
230 | - | - | 230 | ||||||||||||
|
Total operating expenses
|
51,922 | 3,768 | - | 55,690 | ||||||||||||
|
Income before other income and expense
|
10,060 | 4,726 | - | 14,786 | ||||||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest income
|
4 | 7 | - | 11 | ||||||||||||
|
Interest expense
|
(17,208 | ) | (2,792 | ) | - | (20,000 | ) | |||||||||
|
Interest – amortization of deferred financing costs
|
(694 | ) | - | - | (694 | ) | ||||||||||
|
Interest – refinancing costs
|
(16 | ) | - | - | (16 | ) | ||||||||||
|
Equity in earnings
|
1,941 | - | (1,941 | ) | - | |||||||||||
|
Total other expense
|
(15,973 | ) | (2,785 | ) | (1,941 | ) | (20,699 | ) | ||||||||
|
Net (loss) income
|
(5,913 | ) | 1,941 | (1,941 | ) | (5,913 | ) | |||||||||
|
Preferred stock dividends
|
(1,691 | ) | - | - | (1,691 | ) | ||||||||||
|
Preferred stock redemption
|
(3,472 | ) | - | - | (3,472 | ) | ||||||||||
|
Net (loss) income available to common stockholders
|
$ | (11,076 | ) | $ | 1,941 | $ | (1,941 | ) | $ | (11,076 | ) | |||||
|
(i)
|
those items discussed under “Risk Factors” in Item 1A to our annual report on Form 10-K for the year ended December 31, 2010, and in Part II, Item 1A of this report;
|
|
(ii)
|
uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels;
|
|
(iii)
|
the ability of any operators in bankruptcy to reject unexpired lease obligations, modify the terms of our mortgages and impede our ability to collect unpaid rent or interest during the process of a bankruptcy proceeding and retain security deposits for the debtors’ obligations;
|
|
(iv)
|
our ability to sell closed or foreclosed assets on a timely basis and on terms that allow us to realize the carrying value of these assets;
|
|
(v)
|
our ability to negotiate appropriate modifications to the terms of our credit facilities;
|
|
(vi)
|
our ability to manage, re-lease or sell any owned and operated facilities;
|
|
(vii)
|
the availability and cost of capital;
|
|
(viii)
|
changes in our credit ratings and the ratings of our debt securities;
|
|
(ix)
|
competition in the financing of healthcare facilities;
|
|
(x)
|
regulatory and other changes in the healthcare sector;
|
|
(xi)
|
the effect of economic and market conditions generally and, particularly, in the healthcare industry;
|
|
(xii)
|
changes in the financial position of our operators;
|
|
(xiii)
|
changes in interest rates;
|
|
(xiv)
|
the amount and yield of any additional investments;
|
|
(xv)
|
changes in tax laws and regulations affecting real estate investment trusts; and
|
|
(xvi)
|
our ability to maintain our status as a real estate investment trust.
|
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands)
|
||||||||
|
Net (loss) income available to common stockholders
|
$ | (11,076 | ) | $ | 18,680 | |||
|
Elimination of non-cash items included in net income:
|
||||||||
|
Depreciation and amortization
|
25,218 | 14,687 | ||||||
|
Funds from operations available to common stockholders
|
$ | 14,142 | $ | 33,367 | ||||
|
|
Portfolio and Recent Developments
|
|
Payments due by period
|
||||||||||||||||||||
|
Total
|
Less than
1 year
|
1-3 years
|
3-5 years
|
More than
5 years
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||
|
Debt
(1)
|
$ | 1,219,287 | $ | 2,498 | $ | 5,418 | $ | 250,035 | $ | 961,336 | ||||||||||
|
Interest payments on long-term debt
|
873,007 | 80,468 | 160,514 | 154,017 | 478,008 | |||||||||||||||
|
Operating lease obligations
(2)
|
2,621 | 297 | 620 | 654 | 1,050 | |||||||||||||||
|
Total
|
$ | 2,094,915 | $ | 83,263 | $ | 166,552 | $ | 404,706 | $ | 1,440,394 | ||||||||||
|
(1)
|
The $1.2 billion of debt outstanding includes $69 million in borrowings under the $320 million revolving senior secured credit facility due in April 2014, $175 million aggregate principal amount of 7% Senior Notes due January 2016, $200 million aggregate principal amount of 7.5% Senior Notes due February 2020, $575 million aggregate principal amount of 6.75% Senior Notes due October 2022, $20 million of 9.0% subordinated debt maturing in December 2021, $53
million of HUD debt at a 6.61% weighted average annual interest rate maturing between January 2036 and May 2040, and $128 million of HUD Debt at a 4.85% annual interest rate and maturing between January 2040 and January 2045.
|
|
(2)
|
Relates primarily to the lease at the corporate headquarters.
|
|
Exhibit No.
|
||
|
3.1
|
Amended and Restated Bylaws, effective as of the conclusion of the Company’s 2011 Annual Meeting of Stockholders. (Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K, filed on April 20, 2011).
|
|
|
10.1
|
Sixth Amendment to Second Consolidated Amended and Restated Master Lease dated as of March 31, 2011 by and among OHI Asset (PA) Trust as lessor and certain affiliated entities of CommuniCare Health Service as lessees.
|
|
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive Officer.
|
|
|
32.2
|
Section 1350 Certification of the Chief Financial Officer.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|